Breast Cancer is the leading type of cancer in women. According to WHO, one in every 8 women in US is at the risk of developing a breast abnormality in her life time. It is well-established that early diagnosis is very critical in saving a life of a cancer patient. They at NIRAMAI have developed a new cancer screening software that uses machine intelligence over thermography images to enable a low cost, easy to use, portable solution and requires minimal human supervision. Their solution can detect cancer at a much earlier stage than traditional diagnostic methods and self-examination and can therefore improve survival rates. Their method of breast cancer screening can detect tumors 5 times smaller than what clinical exam can detect, is non-contact, painless and free of any radiation, apart from being low-cost, and universally accessible. With their solution, women of all age groups can undergo frequent screening without any side-effects.

U-Systems designed, developed, manufactured and marketed innovative, ultrasound systems and software to assist the radiologist in detection of breast cancer in women with dense breast tissue.

SonoCine is a medical technology company, develops and markets an imaging solution for breast cancer screening. The company develops an automated breast ultrasound system for finding small cancers in women. Its system detects small tumors hidden in dense breast tissue that are missed by mammograms and conventional ultrasound. SonoCine was founded in 2000 and is headquartered in Reno, Nevada.

Hologic engages in the development, manufacture, and supply of medical imaging systems and diagnostic and surgical products focused on the healthcare needs of women. Products The company operates in four segments: Breast Health; Diagnostics; GYN Surgical; and Skeletal Health. BREAST HEALTH PRODUCTS The company's breast health business offers a line of breast imaging products, including the Selenia full field digital mammography system, a series of screen-film mammography systems, breast biopsy image guidance systems, computer-aided detection (CAD) systems for both screen-film and digital mammography, and DirectRay digital detectors. Its breast health business also includes its Interventional Breast Solutions family of products including breast biopsy devices, its MammoSite radiation therapy system and the MammoPad breast cushion. The company's photoconductor coating business, which it acquired in connection with its acquisition of its selenium coating capabilities for its digital detectors, is also a component of its breast health business. DirectRay Digital Detector: The company's DirectRay flat panel detector technology employs an amorphous selenium (a-Se) photoconductor to directly convert x-ray photons into an electrical signal. Selenia Full Field Digital Mammography System: The Selenia full field digital mammography system is based on its proprietary, amorphous selenium DirectRay digital detector, which preserves image quality by using amorphous selenium to directly convert x-rays to electronic signals, without first converting them to light. This direct conversion process preserves image sharpness by eliminating light diffusion.

Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA.

Mirabel Medical Ltd. manufactures and markets medical imaging devices. The company was founded in 1993 by Andrew L. Perlman and Noam Karstaedt and is headquartered in Migdal HaEmek, Israel.

Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.

Shenzhen Hanwei Intelligent Medical Technology Co., Ltd., established on 2018-02-02, Business scope includes general business items:Smart Medical Technology,Technology development of computer hardware and software,Technology Promotion,technology transfer,technical consulting,Technical Services;Computer System Technical Services;Software Development of Medical Informatization,software consulting;Economic Information Consulting(No restricted items);Design of medical products(No restricted items);Educational Consulting(Except for intermediary services);Conference Services;data processing(Bank Card Center in Data Processing,PUEvalue in1.5Except for the above cloud computing data centers);Sales of Class I Medical Devices(above laws,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating);car(Cars not included),bicycle sales;medical cart,Medical examination car sales.(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:R&D, production and sales of robots;IIsales of medical devices.

Exact Sciences Development Co. LLC, part of EXACT Sciences Corp., is an American company. The firm engages in research and development diagnostic test for cancer.

MEDI-FUTURE is a healthcare technology company for women.

VuCOMP designs, develops, and markets computer-aided detection (CAD) systems for automatic analysis of medical images. It offers M-Vu CAD, a CAD system that assists radiologists by automatically identifying areas of a mammogram that are consistent with breast cancer. The company’s M-Vu CAD solution is based on SmartMarks annotations that indicate detected regions with outlines that conform to the shape and size of the regions without obscuring important structures. Its M-Vu CAD systems are compatible with digital mammography systems. VuCOMP was founded in 2001 and is headquartered in Plano, Texas.

Nanoptics fibers are employed in targeting devices for archery and weapons, as well as for illumination in medical devices. Advanced specialty applications requiring low-weight, flexible plastic fiber optics, are the original equipment manufacturer (OEM) of choice. Through research and development of new, inventive, and novel products, Nanoptics continues to create success for its customers. They are committed to providing the greatest product while maintaining the level of customer service.

iCAD Inc. (NASDAQ: ICAD), headquartered in Nashua, New Hampshire, is a medical-device manufacturer. iCAD makes cancer detection and radiation therapy devices. iCAD offers computer aided detection (CAD) and workflow solutions to support detection of breast, prostate and colorectal cancers. The iCAD technology platforms include hardware and software as well as management services to support cancer detection and radiation therapy treatment.

Guizhou Ankang Medical Testing Center Co., Ltd., established on 2014-12-09, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(Clinical Medical Testing Services;Pathological diagnosis service;Medical Research and Experimental Development;diagnostic technology,Technology development for medical technology,Technical Services,technical consulting;technology development in biotechnology,Technical Services,technology transfer,technical consulting;Investment in the medical industry(Use own funds);Commodity Information Consulting Service;Business Consulting Management(Does not include finance,securities,Investment, financing and wealth management information consulting and services);Corporate Training Services(In addition to vocational skills training,Academic training and school running);Technology development of computer software,Technical Services;Maintenance of computer information systems;Information Technology Consulting Services;Information system integration service;Internet of things technology research and development;Chemical product testing service Food testing service;Agriculture and animal husbandry testing services;Drug Testing Service;Environmental Protection Monitoring Service;Water Quality Testing Service;Water Pollution Testing Services;Import and export of goods and technology.(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department))

Shenzhen Gedaosu Biotechnology Co., Ltd., established on 2019-10-10, Business scope includes general business items:Glycobiotechnology research,to develop,Technical Services,technology transfer;Operating import and export business,The licensing program is:Production of kits,Sales;Production of biological reagents,operate

Oxford Glycosciences, part of Financière de Tubize SA, is a British company that operates as a biotechnology company.